190 related articles for article (PubMed ID: 11961159)
1. HLA matching for hematopoietic stem-cell transplants.
Cooper DL
N Engl J Med; 2002 Apr; 346(16):1251-2; author reply 1251-2. PubMed ID: 11961159
[No Abstract] [Full Text] [Related]
2. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.
Petersdorf EW; Hansen JA; Martin PJ; Woolfrey A; Malkki M; Gooley T; Storer B; Mickelson E; Smith A; Anasetti C
N Engl J Med; 2001 Dec; 345(25):1794-800. PubMed ID: 11752355
[TBL] [Abstract][Full Text] [Related]
3. HLA matching for bone marrow transplantation--how much is enough?
Rubinstein P
N Engl J Med; 2001 Dec; 345(25):1842-4. PubMed ID: 11752363
[No Abstract] [Full Text] [Related]
4. [Human leukocyte antigen (HLA)-haploidentical hematopoietic stem cell transplantation for 8 patients with leukemia and review of the literature].
Xie XS; Wan DM; Sun H
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):636-7. PubMed ID: 21122422
[No Abstract] [Full Text] [Related]
5. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
[TBL] [Abstract][Full Text] [Related]
6. Selection of unrelated donors for hematopoietic cell transplantation.
Field T; Anasetti C
Curr Hematol Rep; 2005 Jul; 4(4):270-5. PubMed ID: 16009041
[TBL] [Abstract][Full Text] [Related]
7. Role of HLA in hematopoietic SCT.
Nowak J
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S71-6. PubMed ID: 18978750
[TBL] [Abstract][Full Text] [Related]
8. Immunity and transplantation.
Navarrete CV
Vox Sang; 2004 Jul; 87 Suppl1():39-42. PubMed ID: 15200602
[No Abstract] [Full Text] [Related]
9. [Allogenic stem cell transplantation of adult patients from HLA-mismatch related and unrelated donors; single center experience].
Kitaori K
Rinsho Ketsueki; 2002 Jun; 43(6):433-7. PubMed ID: 12134695
[No Abstract] [Full Text] [Related]
10. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
[TBL] [Abstract][Full Text] [Related]
11. KIR matching in hematopoietic stem cell transplantation.
Bignon JD; Gagne K
Curr Opin Immunol; 2005 Oct; 17(5):553-9. PubMed ID: 16085405
[TBL] [Abstract][Full Text] [Related]
12. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
Greinix HT; Faé I; Schneider B; Rosenmayr A; Mitterschiffthaler A; Pelzmann B; Kalhs P; Lechner K; Mayr WR; Fischer GF
Bone Marrow Transplant; 2005 Jan; 35(1):57-62. PubMed ID: 15531903
[TBL] [Abstract][Full Text] [Related]
13. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
Sasazuki T; Juji T; Morishima Y; Kinukawa N; Kashiwabara H; Inoko H; Yoshida T; Kimura A; Akaza T; Kamikawaji N; Kodera Y; Takaku F
N Engl J Med; 1998 Oct; 339(17):1177-85. PubMed ID: 9780337
[TBL] [Abstract][Full Text] [Related]
14. Non-HLA immunogenetics in hematopoietic stem cell transplantation.
Dickinson AM; Charron D
Curr Opin Immunol; 2005 Oct; 17(5):517-25. PubMed ID: 16085403
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
[TBL] [Abstract][Full Text] [Related]
16. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
[TBL] [Abstract][Full Text] [Related]
17. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
18. Resistant graft failure overcome with allogenic peripheral blood plus bone marrow stem cells.
Arslan O; Seferoğlu A; Gürman G; Ilhan O; Koç H
Haematologia (Budap); 1998; 29(1):47-50. PubMed ID: 9704257
[TBL] [Abstract][Full Text] [Related]
19. [Graft vs. host disease and graft vs. leukemia/tumor effect].
Okamoto S
Nihon Rinsho; 2003 Sep; 61(9):1484-7. PubMed ID: 14515713
[No Abstract] [Full Text] [Related]
20. Effect of HLA matching on outcome of related and unrelated donor transplantation therapy for chronic myelogenous leukemia.
Petersdorf E; Anasetti C; Servida P; Martin P; Hansen J
Hematol Oncol Clin North Am; 1998 Feb; 12(1):107-21. PubMed ID: 9523228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
